BIOMAT Database Logo BIOMAT Database Logo

Synthesis and biological evaluation of novel 2-arylalkylthio-4-amino-6-benzyl pyrimidines as potent HIV-1 non-nucleoside reverse transcriptase inhibitors. 2010

Hua Qin, and Chang Liu, and Jianfang Zhang, and Ying Guo, and Siwei Zhang, and Zhili Zhang, and Xiaowei Wang, and Liangren Zhang, and Junyi Liu
College of Pharmaceutical Sciences, Capital Medical University, Beijing 100069, PR China.

Novel 2-aryalkylthio-4-amino-6-benzylpyrimidines (3a-i), which can be considered as S-DABO and TMC-125 analogue hybrid molecules, have been designed and synthesized as inhibitors of HIV-1 RT. The results clearly indicated that the changes at the N(3)/C(4) position of pyrimidine ring could affect the hydrogen bonds strength and number between N(3)/C(4) and the Lys101 residue which are indispensable for anti-HIV-1 RT activity. The biological activity results are also in accordance with the docking study.

UI MeSH Term Description Entries
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D003198 Computer Simulation Computer-based representation of physical systems and phenomena such as chemical processes. Computational Modeling,Computational Modelling,Computer Models,In silico Modeling,In silico Models,In silico Simulation,Models, Computer,Computerized Models,Computer Model,Computer Simulations,Computerized Model,In silico Model,Model, Computer,Model, Computerized,Model, In silico,Modeling, Computational,Modeling, In silico,Modelling, Computational,Simulation, Computer,Simulation, In silico,Simulations, Computer
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006860 Hydrogen Bonding A low-energy attractive force between hydrogen and another element. It plays a major role in determining the properties of water, proteins, and other compounds. Hydrogen Bonds,Bond, Hydrogen,Hydrogen Bond
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D054303 HIV Reverse Transcriptase A reverse transcriptase encoded by the POL GENE of HIV. It is a heterodimer of 66 kDa and 51 kDa subunits that are derived from a common precursor protein. The heterodimer also includes an RNAse H activity (RIBONUCLEASE H, HUMAN IMMUNODEFICIENCY VIRUS) that plays an essential role the viral replication process. Reverse Transcriptase, HIV,Reverse Transcriptase, Human Immunodeficiency Virus,Transcriptase, HIV Reverse
D018894 Reverse Transcriptase Inhibitors Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. Reverse Transcriptase Inhibitor,Inhibitors, Reverse Transcriptase,Inhibitor, Reverse Transcriptase,Transcriptase Inhibitor, Reverse
D019380 Anti-HIV Agents Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. AIDS Drug,AIDS Drugs,Anti-AIDS Agents,Anti-AIDS Drug,Anti-HIV Agent,Anti-HIV Drug,Anti-AIDS Drugs,Anti-HIV Drugs,Agent, Anti-HIV,Agents, Anti-AIDS,Agents, Anti-HIV,Anti AIDS Agents,Anti AIDS Drug,Anti AIDS Drugs,Anti HIV Agent,Anti HIV Agents,Anti HIV Drug,Anti HIV Drugs,Drug, AIDS,Drug, Anti-AIDS,Drug, Anti-HIV,Drugs, AIDS,Drugs, Anti-AIDS,Drugs, Anti-HIV

Related Publications

Hua Qin, and Chang Liu, and Jianfang Zhang, and Ying Guo, and Siwei Zhang, and Zhili Zhang, and Xiaowei Wang, and Liangren Zhang, and Junyi Liu
Synthesis and biological evaluation of novel 2-arylalkylthio-5-iodine-6-substituted-benzyl-pyrimidine-4(3H)-ones as potent HIV-1 non-nucleoside reverse transcriptase inhibitors.
May 2014, Molecules (Basel, Switzerland),
Hua Qin, and Chang Liu, and Jianfang Zhang, and Ying Guo, and Siwei Zhang, and Zhili Zhang, and Xiaowei Wang, and Liangren Zhang, and Junyi Liu
Synthesis and biological evaluation of novel 6-substituted 5-alkyl-2-(arylcarbonylmethylthio)pyrimidin-4(3H)-ones as potent non-nucleoside HIV-1 reverse transcriptase inhibitors.
April 2008, Bioorganic & medicinal chemistry,
Hua Qin, and Chang Liu, and Jianfang Zhang, and Ying Guo, and Siwei Zhang, and Zhili Zhang, and Xiaowei Wang, and Liangren Zhang, and Junyi Liu
Non-nucleoside HIV-1 reverse transcriptase inhibitors: synthesis and biological evaluation of novel quinoxalinylethylpyridylthioureas as potent antiviral agents.
March 2000, Antiviral chemistry & chemotherapy,
Hua Qin, and Chang Liu, and Jianfang Zhang, and Ying Guo, and Siwei Zhang, and Zhili Zhang, and Xiaowei Wang, and Liangren Zhang, and Junyi Liu
Synthesis and biological evaluation of (±)-benzhydrol derivatives as potent non-nucleoside HIV-1 reverse transcriptase inhibitors.
August 2011, Bioorganic & medicinal chemistry,
Hua Qin, and Chang Liu, and Jianfang Zhang, and Ying Guo, and Siwei Zhang, and Zhili Zhang, and Xiaowei Wang, and Liangren Zhang, and Junyi Liu
2-Amino-6-arylsulfonylbenzonitriles as non-nucleoside reverse transcriptase inhibitors of HIV-1.
June 2001, Journal of medicinal chemistry,
Hua Qin, and Chang Liu, and Jianfang Zhang, and Ying Guo, and Siwei Zhang, and Zhili Zhang, and Xiaowei Wang, and Liangren Zhang, and Junyi Liu
Synthesis and biological evaluation of imidazole thioacetanilides as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.
August 2009, Bioorganic & medicinal chemistry,
Hua Qin, and Chang Liu, and Jianfang Zhang, and Ying Guo, and Siwei Zhang, and Zhili Zhang, and Xiaowei Wang, and Liangren Zhang, and Junyi Liu
Design, synthesis, and biological evaluation of novel 5-Alkyl-6-Adamantylmethylpyrimidin-4(3H)-ones as HIV-1 non-nucleoside reverse-transcriptase inhibitors.
September 2016, Chemical biology & drug design,
Hua Qin, and Chang Liu, and Jianfang Zhang, and Ying Guo, and Siwei Zhang, and Zhili Zhang, and Xiaowei Wang, and Liangren Zhang, and Junyi Liu
Synthesis and biological evaluation of aryl-phospho-indole as novel HIV-1 non-nucleoside reverse transcriptase inhibitors.
January 2011, Journal of medicinal chemistry,
Hua Qin, and Chang Liu, and Jianfang Zhang, and Ying Guo, and Siwei Zhang, and Zhili Zhang, and Xiaowei Wang, and Liangren Zhang, and Junyi Liu
Synthesis and biological evaluation of novel 5-alkyl-2-arylthio-6-((3,4-dihydroquinolin-1(2H)-yl)methyl)pyrimidin-4(3H)-ones as potent non-nucleoside HIV-1 reverse transcriptase inhibitors.
July 2011, Bioorganic & medicinal chemistry,
Hua Qin, and Chang Liu, and Jianfang Zhang, and Ying Guo, and Siwei Zhang, and Zhili Zhang, and Xiaowei Wang, and Liangren Zhang, and Junyi Liu
Synthesis and biological evaluations of sulfanyltriazoles as novel HIV-1 non-nucleoside reverse transcriptase inhibitors.
August 2006, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!